Adenosquamous versus adenocarcinoma of the pancreas: a population-based outcomes analysis
- PMID: 21082275
- PMCID: PMC3023036
- DOI: 10.1007/s11605-010-1378-5
Adenosquamous versus adenocarcinoma of the pancreas: a population-based outcomes analysis
Abstract
Background: Pancreatic adenosquamous carcinoma has historically been characterized as having a more aggressive clinical course than ductal adenocarcinoma. The natural history of this disease, however, is essentially unknown.
Methods: We evaluated the clinical characteristics of all patients with pancreatic adenosquamous carcinoma recorded in the California Cancer Registry 2000-2007 and compared them to those of patients with ductal adenocarcinoma.
Results: Ninety-five patients with pancreatic adenosquamous carcinoma and 14,746 patients with ductal adenocarcinoma were identified. Demographics were similar between subtypes (p > 0.05). Disease stage at presentation was also similar; over 50% of each diagnostic group presented with metastatic disease (p = 0.62). Surgical resection was more common among patients with locoregional adenosquamous carcinoma than adenocarcinoma (p = 0.0004), but rates of adjuvant therapy administration were similar (p > 0.05). The cohorts' median overall survival durations were similar in a Cox proportional hazards model (p = 0.45); overall survival was also similar when only patients with resected disease were considered (p = 0.65). Early stage, resection and receipt of radiation or chemotherapy were favorable independent prognostic factors among patients with adenosquamous carcinoma. The median overall survival duration of patients with resected adenosquamous carcinoma was 12 months (95% CI, 8-52).
Conclusions: Adenosquamous carcinoma has a natural history similar to that of ductal adenocarcinoma when treated with prevalent clinical patterns of care.
Figures

Similar articles
-
Clinical presentation and prognosis of adenosquamous carcinoma of the pancreas - Matched-pair analysis with pancreatic ductal adenocarcinoma.Eur J Surg Oncol. 2021 Jul;47(7):1734-1741. doi: 10.1016/j.ejso.2021.02.011. Epub 2021 Feb 16. Eur J Surg Oncol. 2021. PMID: 33622577
-
415 patients with adenosquamous carcinoma of the pancreas: a population-based analysis of prognosis and survival.J Surg Res. 2012 May 1;174(1):12-9. doi: 10.1016/j.jss.2011.06.015. Epub 2011 Jul 7. J Surg Res. 2012. PMID: 21816433 Free PMC article.
-
Population-based evaluation of adenosquamous carcinoma of the colon and rectum.Dis Colon Rectum. 2012 May;55(5):509-14. doi: 10.1097/DCR.0b013e3182420953. Dis Colon Rectum. 2012. PMID: 22513428 Free PMC article.
-
Surgical outcome of adenosquamous carcinoma of the pancreas.World J Gastroenterol. 2008 Nov 28;14(44):6765-70. doi: 10.3748/wjg.14.6765. World J Gastroenterol. 2008. PMID: 19058301 Free PMC article. Review.
-
Clinicopathological features of adenosquamous pancreatic cancer.Langenbecks Arch Surg. 2011 Feb;396(2):217-22. doi: 10.1007/s00423-010-0677-3. Epub 2010 Jul 9. Langenbecks Arch Surg. 2011. PMID: 20617336 Review.
Cited by
-
Successful pancreatectomy after conversion-intended chemotherapy using gemcitabine and nab-paclitaxel for unresectable adenosquamous carcinoma of the pancreas: a case report.Surg Case Rep. 2024 Aug 16;10(1):189. doi: 10.1186/s40792-024-01989-5. Surg Case Rep. 2024. PMID: 39150596 Free PMC article.
-
Cyclooxygenase-2 Influences Response to Cotargeting of MEK and CDK4/6 in a Subpopulation of Pancreatic Cancers.Mol Cancer Ther. 2018 Dec;17(12):2495-2506. doi: 10.1158/1535-7163.MCT-18-0082. Epub 2018 Sep 25. Mol Cancer Ther. 2018. PMID: 30254182 Free PMC article.
-
Clinical Outcome and Prognostic Factors of Pancreatic Adenosquamous Carcinoma Compared to Ductal Adenocarcinoma-Results from the German Cancer Registry Group.Cancers (Basel). 2022 Aug 16;14(16):3946. doi: 10.3390/cancers14163946. Cancers (Basel). 2022. PMID: 36010939 Free PMC article.
-
Prognostic Analysis and Influencing Serum Biomarkers of Patients With Resectable Pancreatic Adenosquamous Cancer.Front Oncol. 2021 Jan 15;10:611809. doi: 10.3389/fonc.2020.611809. eCollection 2020. Front Oncol. 2021. PMID: 33520722 Free PMC article.
-
Chemotherapy is associated with improved survival in a national cohort of stage IV pancreatic adenosquamous carcinoma.J Gastrointest Oncol. 2022 Dec;13(6):3207-3215. doi: 10.21037/jgo-22-434. J Gastrointest Oncol. 2022. PMID: 36636088 Free PMC article.
References
-
- Hruban R, Pitman M, Klimstra D. Tumors of the pancreas. In: Silverberg S, Sobin L, editors. AFIP atlas of tumor pathology. Washington, DC: American Registry of Pathology; 2007. pp. 177–81.